Point72 Asset Management
AURA icon

Point72 Asset Management’s Aura Biosciences AURA Stock Holding History

Point72 Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Sell
21,708
-32,984
-60% -$189K ﹤0.01% 3573
2025
Q4 		$298K Buy
+54,692
New +$325K ﹤0.01% 3476

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management's AURA Position: Q1 2026 in Review

Point72 Asset Management reduced its Aura Biosciences (AURA) stake by 60% in Q1 2026, selling an estimated $189K and leaving 21,708 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

Point72 Asset Management first reported a position in AURA in Q4 2025 and has held it in 2 quarters since. The position peaked at $298K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Point72 Asset Management held 21,708 shares of Aura Biosciences worth $145K as of Q1 2026.
  • Point72 Asset Management sold 32,984 Aura Biosciences shares in Q1 2026, an estimated $189K.
  • Aura Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3573 holding.
  • Point72 Asset Management first reported a position in Aura Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's Aura Biosciences position peaked at $298K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.